Cost-effectiveness of ivosidenib in patients with previously treated isocitrate dehydrogenase 1 (IDH1)-mutant cholangiocarcinoma: An Italian perspective

Hepatobiliary & Pancreatic Diseases International · Elsevier

Аннотация

Publication date: August 2026 Source: Hepatobiliary & Pancreatic Diseases International, Volume 25, Issue 4 Author(s): Jacopo Giuliani, Emilia Durante, Marco Muraro, Silvia Muraro, Marina Tommasi, Francesco Fiorica, Teodoro Sava

Читать у издателя →

Похожие статьи